The replay of our Investor and Analyst Event is now available: bit.ly/43PqFWS

Thanks to Professor Verkade for joining us! We are delighted that AX-0810 progressing to the clinic.

#Axiomer #RNAEditing $PRQR

Join us in 60 mins for our virtual Investor and Analyst Event with ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen).

Register for the event here: bit.ly/3Lb7GzE

#Axiomer #RNAEditing $PRQR

Join us Nov 3 at 10:00 ET for our virtual Investor and Analyst Event with the ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen).

Register for the event here: bit.ly/3Lb7GzE

#Axiomer #RNAEditing

October marks #RettSyndromeAwarenessMonth, a time to shine a light on Rett syndrome.

At ProQR, we are proud to partner with the Rett Syndrome Research Trust developing #Axiomer #RNAEditing oligonucleotides to target genetic variants that cause Rett syndrome.

We’re excited to share that our CTA for the Phase 1 study of AX-0810 in healthy volunteers has been authorized!

Join our virtual Investor and Analyst Event Nov 3, 10:00 ET.

For more details, check out the PR: bit.ly/3LjRCLX

#Axiomer #RNAEditing

David, Senior Scientist at ProQR, plays a key role in advancing cell biology research while also contributing to team leadership and workplace culture.

Meet the rest of our team at: bit.ly/4nbVZWR

#Axiomer #RNAEditing #TeamProQR

Lemelinda pairs her passion for RNA biology with research, protocol development & biosafety support, while also fostering a strong community at ProQR through our Coffee & Collaboration Café.

Meet more of the ProQR team at: bit.ly/45ZFtmq

#Axiomer #RNAEditing #TeamProQR

Today we announced our Second Quarter 2025 Operating and Financial Results. Read the press release here: bit.ly/4fwEU7Y
$PRQR #RNAEditing #Axiomer

Great to connect with the local community at the Dutch Medicines Summer Afternoon!

Our VP Axiomer Science, Lenka van Sint Fiet, demonstrated how #Axiomer is driving progress toward potentially transformative therapies.

#RNAEditing #DutchBioScienceWeek

As R&D Team Manager at ProQR, Lorenza drives scientific collaboration and project planning while also championing inclusivity as part of our DEI team.

Meet the ProQR team at: bit.ly/4m4oZzs

#Axiomer #RNAEditing #TeamProQR

We are happy to announce the submission of a CTA to the EMA to initiate a Phase 1 clinical trial in healthy volunteers for AX-0810 targeting NTCP.

Check out the press release for more details: bit.ly/4ljFzuQ

#Axiomer #RNAEditing #BiotechNews

At ProQR, we’re proud to foster a culture where everyone feels safe to be themselves. To celebrate #Pride, our DEI team hosted a rainbow themed coffee & collaboration event with multicoloured cakes and a movie night featuring an LGBTQIA+ film and discussion.

#Inclusivity #RNAEditing #Axiomer

This week we held our biannual Axiomer Summit event – a day of vibrant discussions, insightful presentations, and an engaging poster session focused on our science. Thanks to our Scientific Advisory Board and Board members for joining this exciting exchange!

#RNAEditing #Axiomer #Biotech

From Amsterdam to New Orleans to San Diego – the month of May brought many connections with the field at #EASL, #ASGCT2025, and #TIDESUSA.

Posters and presentations from ASGCT and TIDES are available on our website under Presentations and Publications.

bit.ly/4kPCen7

Today we announced our First Quarter Operating and Financial Results.

Read the press release here: bit.ly/4dhMSRe

$PRQR #RNAEditing #Axiomer

ProQR is officially a Great Place to Work!

We’re proud to foster a culture where innovation, collaboration, and growth thrive—driven by our amazing team and our mission to develop transformative RNA therapies.

bit.ly/42LdvZR

#GPTW #Biotech #RNAEditing #Axiomer